ASTELLAS PHARMA EUROPE LTD.
🇬🇧United Kingdom
A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
Phase 4
Completed
- Conditions
- Non-diabetic Painful Peripheral PolyneuropathyPeripheral Nerve Injury (PNI)Postherpetic Neuralgia (PHN)
- Interventions
- First Posted Date
- 2012-10-24
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 568
- Registration Number
- NCT01713426
- Locations
- 🇦🇲
Site 101 Medical Union 2, Yerevan, Armenia
🇦🇲Site 102 Medical Center Erebuni, Yerevan, Armenia
🇦🇲Site 103 Scientific research Institute of physiotherapy, Yerevan, Armenia
Vesitirim™ in Men Postmarketing Observational Study
Completed
- Conditions
- Lower Urinary Tract Symptoms (LUTS)Overactive Bladder (OAB)
- Interventions
- Drug: Vesitirim™ (Solifenacin)
- First Posted Date
- 2012-07-13
- Last Posted Date
- 2013-01-17
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT01639794
- Locations
- 🇮🇪
Site 2 - Mercy University Hospital, Cork, Ireland
🇮🇪Site: 4 - Tallaght Hospital, Dublin, Ireland
🇮🇪Site: 1 - St James Hopsital, Dublin, Ireland
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.
Phase 3
Completed
- Conditions
- Urologic DiseasesUrinary Bladder, OveractiveUrinary Bladder Diseases
- Interventions
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 1887
- Registration Number
- NCT01638000
- Locations
- 🇦🇲
Site: 37406, Yerevan, Armenia
🇦🇲Site: 37404, Yerevan, Armenia
🇦🇲Site: 37403, Yerevan, Armenia
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Phase 2
Completed
- Conditions
- Heart TransplantationKidney TransplantationLiver Transplantation
- Interventions
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT01614665
- Locations
- 🇨🇿
Site CZ61, Prague 5, Czechia
🇫🇷Site FR33, Bron Cedex, France
🇫🇷Site FR32, Paris Cedex 15, France
An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics
Phase 1
Terminated
- Conditions
- Overactive BladderHealthy Subjects
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT01540786
- Locations
- 🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Phase 4
Completed
- Conditions
- Liver TransplantationKidney TransplantationHeart Transplantation
- Interventions
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT01371331
- Locations
- 🇧🇪
Site 40, Brussels, Belgium
🇫🇷Site: 60, Bron Cedex, France
🇩🇪Site 31, Hannover, Germany
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Phase 4
Terminated
- Conditions
- Heart TransplantationKidney TransplantationLiver Transplantation
- Interventions
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT01371344
- Locations
- 🇧🇪
Site BE40 Clinique Univ. Saint Luc, Brussels, Belgium
🇫🇷Site FR60 Groupement Hospitalier EST, Bron, France
🇫🇷Site FR61 Hopital Robert Debre, Paris Cedex 19, France
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Phase 2
Active, not recruiting
- Conditions
- Heart TransplantationIntestine TransplantationLung TransplantationLiver TransplantationKidney Transplantation
- Interventions
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Astellas Pharma Europe Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT01294020
- Locations
- 🇧🇪
Site BE21, Brussels, Belgium
🇧🇪Site BE22, Brussels, Belgium
🇨🇿Site CZ42, Prague 5, Czechia
A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants with Chronic Kidney Disease
Phase 3
Not yet recruiting
- Conditions
- Anemia in Pediatric Participants with Chronic Kidney Disease.Anemia in Chronic Kidney Disease
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Astellas
- Target Recruit Count
- 100
- Registration Number
- LBCTR2024015495